Mark Bach
Vermogen: 69 171 $ op 31-07-2026
Vermogen: 69 171 $ op 31-07-2026
Dr. Mark A. Bach, MD, is Senior Vice President-Clinical Development bij Ascendis Pharma A/S. Dr. Bach was voordien werkzaam als Chief Executive Officer bij Accumulus Synergy, Inc, als Head-Asia Pacific Medical Sciences bij Janssen Pharmaceuticals, Inc, als Vice President-Research & Development bij Janssen Pharmaceutical KK, en als VP-Clinical Research Operations Worldwide bij Merck & Co, Inc. Hij behaalde zijn doctoraatsdiploma aan het Carleton College, een doctoraatsdiploma aan de Universiteit van Chicago en een doctoraatsdiploma aan het Baylor College of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2024 | 4.320 ( 0% ) | 69 171 $ | 31-07-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 18-09-2024 |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Algemeen Directeur | 01-10-2020 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01-08-2019 |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | 01-11-2012 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Health Technology |
Carleton College
Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau